種屬

人

組織來(lái)源

乳腺癌

培養(yǎng)體系

RPMI1640+10%FBS ＋1% P/S

培養(yǎng)基

RPMI1640培養(yǎng)基

背景描述

源自一位48歲女性乳癌患者。 Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.

傳代消化

1:2傳代,消化3-5分鐘 ， 3天可長(zhǎng)滿。

形態(tài)/生長(zhǎng)

上皮細(xì)胞 ， 貼壁生長(zhǎng)

培養(yǎng)條件

氣相：空氣，95%；二氧化碳，5%； 溫度：37℃

凍存條件

90%FBS，DMSO 10%, 或使用無(wú)血清凍存液Methods: Public datasets were used as our source of multi-omics data. Differential analysis was performed via the edgeR package. A prognostic immune signature was identified by univariate Cox analysis, and we constructed an integrative tumor-associated immune genes (TAIG) model from the mriate Cox results. In order to interrogate and identify the related crosstalk,